Clinical Trial Update: MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 proof-of-concept study of MDCO-216 infusions in acute coronary syndrome patients, evaluating intravascular ultrasound and lipid/biomarker surrogates…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome

Drugs mentioned

• MDCO-216

Snippet

Sponsor: The Medicines Company | Conditions: Acute Coronary Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-13